vimarsana.com
Home
Live Updates
Generix Group - Half-year 2021/2022 Results | EBITDA rate 13,5% : vimarsana.com
Generix Group - Half-year 2021/2022 Results | EBITDA rate 13,5%
PRESS RELEASE Paris, December 8, 2021 H1 results 2021/2022 Ebitda rate: 13.5% Continued strategic investments in R&D Strengthening of sales and marketing forces, particularly in North
Related Keywords
United States
,
Paris
,
France General
,
France
,
America
,
American
,
,
Generix Soft Group Romania
,
Generix Group
,
Danone
,
Collaborative Saas Solutions
,
Carrefour
,
Retail Ecosystems
,
North American
,
Generix Soft Group
,
North America
,
General Manager
,
Collaborative Supply Chain
,
Generix Supply Chain Hub
,
Supply Chain Hub
,
Supply Chain
,
Euronext Paris
,
Generix
,
Group
,
Calf
,
Ear
,
021
,
022
,
Results
,
Bitda
,
Gate
,
vimarsana.com © 2020. All Rights Reserved.